{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:02:00Z","timestamp":1777104120358,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006044","name":"Astellas Pharma Europe","doi-asserted-by":"publisher","award":["ISR CZ-110-RG-14"],"award-info":[{"award-number":["ISR CZ-110-RG-14"]}],"id":[{"id":"10.13039\/501100006044","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11255-020-02774-7","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T07:15:59Z","timestamp":1610090159000},"page":"1089-1095","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-5926","authenticated-orcid":false,"given":"Jan","family":"Krhut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wohlfahrt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Pudich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli\u0161ka","family":"Kufov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Borovi\u010dka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol\u00edna","family":"B\u00edlkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radek","family":"S\u00fdkora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Mokri\u0161","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"C\u00edfkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Zachoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Zvara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"issue":"4","key":"2774_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/MOU.0000000000000290","volume":"26","author":"CJ Harris","year":"2016","unstructured":"Harris CJ, Lemack GE (2016) Neurourologic dysfunction: evaluation, surveillance and therapy. Curr Opin Urol 26(4):290\u2013294","journal-title":"Curr Opin Urol"},{"issue":"10","key":"2774_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00345-018-2345-0","volume":"36","author":"E Kreydin","year":"2018","unstructured":"Kreydin E, Welk B, Chung D, Clemens Q, Yang C, Danforth T et al (2018) Surveillance and management of urologic complications after spinal cord injury. World J Urol 36(10):1545\u20131553","journal-title":"World J Urol"},{"issue":"11","key":"2774_CR3","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1442-2042.2010.02635.x","volume":"17","author":"M Watanabe","year":"2010","unstructured":"Watanabe M, Yamanishi T, Honda M, Sakakibara R, Uchiyama T, Yoshida K (2010) Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and\/or low-compliance bladder. Int J Urol 17(11):931\u2013936","journal-title":"Int J Urol"},{"issue":"2","key":"2774_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/sc.2016.168","volume":"55","author":"H Sugiyama","year":"2017","unstructured":"Sugiyama H, Uemura O, Mori T, Okisio N, Unai K, Liu M (2017) Effect of imidafenacin on the urodynamic parameters of patients with indwelling bladder catheters due to spinal cord injury. Spinal Cord 55(2):187\u2013191","journal-title":"Spinal Cord"},{"issue":"1","key":"2774_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/nau.22505","volume":"33","author":"CR Chapple","year":"2014","unstructured":"Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC (2014) Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn 33(1):17\u201330","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"2774_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.eururo.2015.09.007","volume":"69","author":"GM Rosa","year":"2016","unstructured":"Rosa GM, Ferrero S, Nitti VW, Wagg A, Sallem T, Chapple CR (2016) Cardiovascular safety of \u03b23-adrenoceptor agonists for the treatment of patients with overactive bladder syndrome. Eur Urol 69(2):311\u2013323","journal-title":"Eur Urol"},{"key":"2774_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-03040-x","author":"E El Helou","year":"2019","unstructured":"El Helou E, Labaki C, Chebel R, El Helou J, Abi Tayeh G, Jalkh G et al (2019) The use of mirabegron in neurogenic bladder: a systematic review. World J Urol. https:\/\/doi.org\/10.1007\/s00345-019-03040-x","journal-title":"World J Urol"},{"issue":"4","key":"2774_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/cphy.c130045","volume":"4","author":"S Hou","year":"2014","unstructured":"Hou S, Rabchevsky AG (2014) Autonomic consequences of spinal cord injury. Compr Physiol 4(4):1419\u20131453","journal-title":"Compr Physiol"},{"issue":"2","key":"2774_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.msard.2015.02.002","volume":"4","author":"JM Racosta","year":"2015","unstructured":"Racosta JM, Sposato LA, Morrow SA, Cipriano L, Kimpinski K, Kremenchutzky M (2015) Cardiovascular autonomic dysfunction in multiple sclerosis: a meta-analysis. Mult Scler Relat Disord 4(2):104\u2013111","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"2774_CR10","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/nau.23566","volume":"37","author":"J Krhut","year":"2018","unstructured":"Krhut J, Borovi\u010dka V, B\u00edlkov\u00e1 K, S\u00fdkora R, M\u00edka D, Mokri\u0161 J et al (2018) Efficacy and safety of mirabegron for the treatment of neurogenic detrusor overactivity-prospective, randomized, double-blind, placebo-controlled study. Neurourol Urodyn 37(7):2226\u20132233","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"2774_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","volume":"32","author":"C Mitchell","year":"2019","unstructured":"Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC et al (2019) Gidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 32(1):1\u201364","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"2774_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/sc.2012.158","volume":"52","author":"BB Lee","year":"2014","unstructured":"Lee BB, Cripps RA, Fitzharris M, Wing PC (2014) The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate. Spinal Cord 52(2):110\u2013116","journal-title":"Spinal Cord"},{"issue":"2","key":"2774_CR13","first-page":"133","volume":"2","author":"VT Grigorean","year":"2009","unstructured":"Grigorean VT, Sandu AM, Popescu M, Iacobini MA, Stoian R, Neascu C et al (2009) Cardiac dysfunctions following spinal cord injury. J Med Life 2(2):133\u2013134","journal-title":"J Med Life"},{"issue":"6","key":"2774_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.apmr.2015.01.018","volume":"96","author":"JM Wecht","year":"2015","unstructured":"Wecht JM, Weir JP, Galea M, Martinez S, Bauman WA (2015) Prevalence of abnormal systemic hemodynamics in veterans with and without spinal cord injury. Arch Phys Med Rehabil 96(6):1071\u20131079","journal-title":"Arch Phys Med Rehabil"},{"key":"2774_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.autneu.2017.05.002","volume":"209","author":"KC Eldahan","year":"2018","unstructured":"Eldahan KC, Rabchevsky AG (2018) Autonomic dysreflexia after spinal cord injury: systemic pathophysiology and methods of management. Auton Neurosci 209:59\u201370","journal-title":"Auton Neurosci"},{"key":"2774_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.autneu.2017.02.004","volume":"209","author":"F Biering-S\u00f8rensen","year":"2018","unstructured":"Biering-S\u00f8rensen F, Biering-S\u00f8rensen T, Liu N, Malmqvist L, Wecht JM, Krassioukov A (2018) Alterations in cardiac autonomic control in spinal cord injury. Auton Neurosci 209:4\u201318","journal-title":"Auton Neurosci"},{"issue":"1","key":"2774_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1179\/2045772313Y.0000000161","volume":"37","author":"C Driussi","year":"2014","unstructured":"Driussi C, Ius A, Bizzarini E, Antonini-Canterin F, d\u2019Andrea A, Bossone E et al (2014) Structural and functional left ventricular impairment in subjects with chronic spinal cord injury and no overt cardiovascular disease. J Spinal Cord Med 37(1):85\u201392","journal-title":"J Spinal Cord Med"},{"key":"2774_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2377-13-128","volume":"13","author":"E Kingwell","year":"2013","unstructured":"Kingwell E, Marriott JJ, Jett\u00e9 N, Pringsheim T, Makhani N, Morrow SA et al (2013) Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol 13:128","journal-title":"BMC Neurol"},{"issue":"5","key":"2774_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/135245850100700509","volume":"7","author":"P Flachenecker","year":"2001","unstructured":"Flachenecker P, Reiners K, Krauser M, Wolf A, Toyka KV (2001) Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability. Mult Scler 7(5):327\u2013334","journal-title":"Mult Scler"},{"issue":"6","key":"2774_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/NRL.0000000000000064","volume":"20","author":"TB Kaplan","year":"2015","unstructured":"Kaplan TB, Berkowitz AL, Samuels MA (2015) Cardiovascular dysfunction in multiple sclerosis. Neurologist 20(6):108\u2013114","journal-title":"Neurologist"},{"key":"2774_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.autneu.2015.06.001","volume":"193","author":"JM Racosta","year":"2015","unstructured":"Racosta JM, Kimpinski K, Morrow SA, Kremenchutzky M (2015) Autonomic dysfunction in multiple sclerosis. Auton Neurosci 193:1\u20136","journal-title":"Auton Neurosci"},{"issue":"8","key":"2774_CR22","doi-asserted-by":"publisher","first-page":"16920","DOI":"10.3390\/ijms160816920","volume":"16","author":"A Pint\u00e9r","year":"2015","unstructured":"Pint\u00e9r A, Cseh D, S\u00e1rk\u00f6zi A, Illigens BM, Siepmann T (2015) Autonomic dysregulation in multiple Sclerosis. Int J Mol Sci 16(8):16920\u201316952","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2774_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jash.2018.08.001","volume":"12","author":"WB White","year":"2018","unstructured":"White WB, Siddiqui E, Tat T, Franks B, Schermer CR (2018) Cardiovascular safety of mirabegron: analysis of an integrated clinical trial database of patients with overactive bladder syndrome. J Am Soc Hypertens 12(11):768\u201378.e1","journal-title":"J Am Soc Hypertens"},{"issue":"5","key":"2774_CR24","doi-asserted-by":"publisher","first-page":"e12944","DOI":"10.1111\/ijcp.12944","volume":"71","author":"MJ Drake","year":"2017","unstructured":"Drake MJ, MacDiarmid S, Chapple CR, Esen A, Athanasiou S, Cambronero Santos J et al (2017) Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE). Int J Clin Pract 71(5):e12944","journal-title":"Int J Clin Pract"},{"issue":"12","key":"2774_CR25","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/iju.13218","volume":"23","author":"T Katoh","year":"2016","unstructured":"Katoh T, Kuwamoto K, Kato D, Kuroishi K (2016) Real-world cardiovascular assessment of mirabegron treatment in patients with overactive bladder and concomitant cardiovascular disease: results of a Japanese post-marketing study. Int J Urol 23(12):1009\u20131015","journal-title":"Int J Urol"},{"issue":"1","key":"2774_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/luts.12190","volume":"11","author":"M Yoshida","year":"2019","unstructured":"Yoshida M, Nozawa Y, Kato D, Tabuchi H, Kuroishi K (2019) Safety and effectiveness of mirabegron in patients with overactive bladder aged \u226575 years: analysis of a Japanese post-marketing study. Low Urin Tract Symptoms 11(1):30\u201338","journal-title":"Low Urin Tract Symptoms"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02774-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02774-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02774-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T14:15:04Z","timestamp":1621865704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02774-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2774"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02774-7","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"19 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the Institutional Review Board of University Hospital Ostrava, Czech Republic (No.26514).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}